Response to b-cell depletion can be predicted
Response to b-cell depletion can be predicted
https://www.pnas.org/content/early/2020 ... 9117.short
Significance
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). B cells play a key role in MS immunopathology, as demonstrated by the success of B cell-directed therapies; however, the target antigen of MS remains unknown.
Using a combination of ELISpot-based prescreening of peripheral blood mononuclear cells followed by investigation of antibody specificity with a CNS antigen array, we identified a population of MS patients characterized by a highly active B cell response.
These individuals with MS, who have active B cell responses, exhibited heterogeneous interindividual anti-CNS antibody responses, although the antigenic specificity of the antibodies remained stable over time for each individual.
Abstract
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS), with characteristic inflammatory lesions and demyelination.
The clinical benefit of cell-depleting therapies targeting CD20 has emphasized the role of B cells and autoantibodies in MS pathogenesis. We previously introduced an enzyme-linked immunospot spot (ELISpot)-based assay to measure CNS antigen-specific B cells in the blood of MS patients and demonstrated its usefulness as a predictive biomarker for disease activity in measuring the successful outcome of disease-modifying therapies (DMTs).
Here we used a planar protein array to investigate CNS-reactive antibodies in the serum of MS patients as well as in B cell culture supernatants after polyclonal stimulation. Anti-CNS antibody reactivity was evident in the sera of the MS cohort, and the antibodies bound a heterogeneous set of molecules, including myelin, axonal cytoskeleton, and ion channel antigens, in individual patients. Immunoglobulin reactivity in supernatants of stimulated B cells was directed against a broad range of CNS antigens. A group of MS patients with a highly active B cell component was identified by the ELISpot assay. Those antibody reactivities remained stable over time.
These assays with protein arrays identify MS patients with a highly active B cell population with antibodies directed against a swathe of CNS proteins.
-
- Similar Topics
- Replies
- Views
- Last post
-
-
Response to Copaxone can be predicted
by frodo » Thu Nov 07, 2019 7:11 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 0 Replies
- 1917 Views
-
Last post by frodo
Thu Nov 07, 2019 7:11 am
-
-
- 0 Replies
- 3260 Views
-
Last post by frodo
Thu May 16, 2019 8:09 am
-
-
T-cell analysis predicts response to Natalizumab
by frodo » Thu Sep 05, 2019 6:39 am » in MS Etiology and Pathogenesis - 0 Replies
- 686 Views
-
Last post by frodo
Thu Sep 05, 2019 6:39 am
-
-
- 0 Replies
- 238 Views
-
Last post by jimmylegs
Sun Aug 30, 2020 10:48 am
-
-
Clinical course can be predicted
by frodo » Thu Jul 30, 2020 11:49 pm » in MS Etiology and Pathogenesis - 0 Replies
- 232 Views
-
Last post by frodo
Thu Jul 30, 2020 11:49 pm
-
-
-
one of the mi-RNA predicts response to interferon
by frodo » Fri Mar 13, 2020 4:50 am » in MS Etiology and Pathogenesis - 0 Replies
- 2005 Views
-
Last post by frodo
Fri Mar 13, 2020 4:50 am
-
-
-
biomarker for response to IFNbeta
by frodo » Wed Aug 12, 2020 10:58 am » in MS Etiology and Pathogenesis - 0 Replies
- 265 Views
-
Last post by frodo
Wed Aug 12, 2020 10:58 am
-
-
-
biomarker for response to interferon beta-1b
by frodo » Tue Jun 09, 2020 2:38 am » in MS Etiology and Pathogenesis - 0 Replies
- 262 Views
-
Last post by frodo
Tue Jun 09, 2020 2:38 am
-
-
-
Biomarker for response to interferon: ADC values
by frodo » Thu Aug 20, 2020 12:03 am » in MS Etiology and Pathogenesis - 0 Replies
- 177 Views
-
Last post by frodo
Thu Aug 20, 2020 12:03 am
-